Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

BRIEF-Correvio Announces Intention To Explore Strategic Alternatives To Maximize Stakeholder Value

Published 2019-12-11, 08:17 a/m
Updated 2019-12-11, 02:03 p/m
© Reuters.  BRIEF-Correvio Announces Intention To Explore Strategic Alternatives To Maximize Stakeholder Value

Dec 11 (Reuters) - Correvio Pharma Corp CORV.TO :

* CORREVIO ANNOUNCES INTENTION TO EXPLORE STRATEGIC ALTERNATIVES TO MAXIMIZE STAKEHOLDER VALUE

* CORREVIO PHARMA CORP - POTENTIAL STRATEGIC ALTERNATIVES THAT MAY BE EVALUATED INCLUDE, BUT ARE NOT LIMITED TO, AN ACQUISITION, MERGER

* CORREVIO PHARMA - TAKING STEPS TO REDUCE OPERATING COSTS OUTSIDE CORE EUROPEAN COMMERCIAL BUSINESS & TRANSACTION COMMITTEE FORMED WITHIN BOARD

* CORREVIO PHARMA CORP - CORREVIO'S EX-U.S. COMMERCIAL PORTFOLIO IS ON TRACK TO DELIVER GREATER THAN $30 MILLION IN REVENUE IN 2019

* CORREVIO PHARMA - WILL IMMEDIATELY BEGIN PREPARATIONS FOR A POTENTIAL STRATEGIC TRANSACTION WHILE CO AWAITS U.S. FDA'S DECISION REGARDING BRINAVESS

* CORREVIO PHARMA - CO'S NDA SEEKING APPROVAL FOR BRINAVESS IS UNDER REVIEW BY FDA WITH TARGET ACTION DATE OF DEC 24, 2019 UNDER PDUFA

* CORREVIO PHARMA CORP - INTENDS TO REDUCE ITS OPERATING COSTS IN NORTH AMERICA

* CORREVIO PHARMA - CONCENTRATING ITS RESOURCES ON ONLY ESSENTIAL COMMERCIAL & BUSINESS DEVELOPMENT ACTIVITIES

* CORREVIO PHARMA CORP - HAS RETAINED PIPER JAFFRAY TO ASSIST IN ITS REVIEW OF STRATEGIC ALTERNATIVES

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.